CLINICAL OUTCOMES: RESTORESENSOR STUDY SPINAL CORD STIMULATION
The RestoreSensor™ Clinical Study demonstrates that patients using AdaptiveStim™ experienced improved pain relief with no loss of convenience, or improved convenience with no loss of pain relief, compared with using conventional stimulation.
Specifically, 88.7%* of patients reported better pain relief vs. conventional stimulation.
AdaptiveStim is safe and effective in providing pain relief and/or convenience compared with conventional stimulation.
The RestoreSensor Clinical Study was a prospective, multicenter, open-label, randomized, crossover, 16-week trial. Study details can be found in the Clinical Summary for Advanced Pain Therapy Using Neurostimulation for Chronic Pain.
Access clinical summary and other manuals from the Medtronic Manual Library. Search by the product name (for example, RestoreSensor) or model number (for example, 97714). You may also call 800-961-9055 for a copy of a manual.
RestoreSensor® Clinical Study compared AdaptiveStim stimulation to Medtronic conventional stimulation; 88.7% is based on analysis of one of two questions that comprised the primary endpoint of improved convenience and/or better pain relief. Percentage based on respondents who completed the pain relief question.